11 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Pneumocystis pneumonia (PCP ... Opportunistic #Infections #OIs ... #HIVAIDS #IDSA ... #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Pneumocystis pneumonia (PCP ... Opportunistic #Infections #OIs ... #HIVAIDS #IDSA ... #management #pharmacology
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Differentiation Syndrome in APML ... Imaging: CXR- pulmonary ... initiation • Differential ... fluid overload, PCC ... #diagnosis #management
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
Clindamycin in case of PCN ... residual lesion or is ... Lung Abscess Differential ... Lung #Abscess #pulmonary ... #differential #
Salicylate Poisoning - Toxicology

Acute toxicity = vomiting, tachypnea, tinnitus, diaphoresis, and lethargy. This may progress to
Salicylate Poisoning - Toxicology ... Cerebral and pulmonary ... mortality rate is ... #Pharmacology # ... Diagnosis #Management
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
It is important ... with presence of pulmonary ... #diagnosis #differential ... #algorithm #management ... icu #clinical #pharmacology
Increased Airway Pressure - Guidelines for Crises in Anaesthesia

Using these steps from start to end should
airway device is ... reservoir bag and APL ... o Aspiration, pulmonary ... Airway #Pressure #Differential ... Checklist #Diagnosis #Management
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
Lymphadenitis, pulmonary ... leukoencephalopathy (PML ... Leishmaniasis Differential ... Inflammatory #Syndrome #Differential ... #Diagnosis #Management
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
IDSA Recommendations ... Effusion Lymphoma (PEL ... KaposiSarcoma #Castlemans #IDSA ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Prevention and Treatment of Pneumocystis Pneumonia (PCP) in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
IDSA Recommendations ... every 3 months) is ... Pneumocystis #Pneumonia #IDSA ... infections #HIVAIDS #management ... #pharmacology